Atlas Capital Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03K | Hold |
40
| – | – | ﹤0.01% | 881 |
|
|
2025
Q1 | $408 | Hold |
40
| – | – | ﹤0.01% | 950 |
|
|
2024
Q4 | $558 | Buy |
+40
| New | +$558 | ﹤0.01% | 900 |
|
|
2024
Q3 | – | Sell |
-40
| Closed | -$744 | – | 942 |
|
|
2024
Q2 | $744 | Buy |
+40
| New | +$744 | ﹤0.01% | 860 |
|
|
2024
Q1 | – | Sell |
-40
| Closed | -$339 | – | 942 |
|
|
2023
Q4 | $339 | Hold |
40
| – | – | ﹤0.01% | 873 |
|
|
2023
Q3 | $357 | Hold |
40
| – | – | ﹤0.01% | 850 |
|
|
2023
Q2 | $345 | Hold |
40
| – | – | ﹤0.01% | 870 |
|
|
2023
Q1 | $421 | Hold |
40
| – | – | ﹤0.01% | 881 |
|
|
2022
Q4 | $1.36K | Hold |
40
| – | – | ﹤0.01% | 846 |
|
|
2022
Q3 | $1.92K | Hold |
40
| – | – | ﹤0.01% | 836 |
|
|
2022
Q2 | $2.28K | Hold |
40
| – | – | ﹤0.01% | 902 |
|
|
2022
Q1 | $3.23K | Hold |
40
| – | – | ﹤0.01% | 824 |
|
|
2021
Q4 | $8.11K | Hold |
40
| – | – | ﹤0.01% | 745 |
|
|
2021
Q3 | $10.8K | Hold |
40
| – | – | ﹤0.01% | 716 |
|
|
2021
Q2 | $10.3K | Hold |
40
| – | – | ﹤0.01% | 738 |
|
|
2021
Q1 | $12K | Hold |
40
| – | – | ﹤0.01% | 654 |
|
|
2020
Q4 | $10.2K | Buy |
+40
| New | +$10.2K | ﹤0.01% | 589 |
|
|
2020
Q3 | – | Sell |
-40
| Closed | -$13.9K | – | 488 |
|
|
2020
Q2 | $13.9K | Hold |
40
| – | – | ﹤0.01% | 583 |
|
|
2020
Q1 | $10.7K | Hold |
40
| – | – | ﹤0.01% | 580 |
|
|
2019
Q4 | $13K | Hold |
40
| – | – | ﹤0.01% | 572 |
|
|
2019
Q3 | $10.9K | Hold |
40
| – | – | ﹤0.01% | 570 |
|
|
2019
Q2 | $21.3K | Sell |
40
-46
| -53% | -$24.6K | 0.01% | 552 |
|
|
2019
Q1 | $43.1K | Hold |
86
| – | – | 0.02% | 432 |
|
|
2018
Q4 | $42.2K | Sell |
86
-360
| -81% | -$177K | 0.02% | 424 |
|
|
2018
Q3 | $360K | Buy |
446
+406
| +1,015% | +$328K | 0.12% | 215 |
|
|
2018
Q2 | $29K | Hold |
40
| – | – | 0.01% | 424 |
|
|
2018
Q1 | $63.8K | Buy |
+40
| New | +$63.8K | 0.02% | 401 |
|